SomnoMed Limited (ASX:SOM)

Neil Verdal-Austin
CEO & MD
Market Cap (AUD): 195.31M
Sector: Health Care
Last Trade (AUD): 2.36 +0 (+0%)
Tab Bar

1. About

SomnoMed Limited (ASX:SOM) provides treatment solutions for sleep-related breathing disorders including obstructive sleep apnea, snoring and bruxism. 

SomnoMed was commercialized following extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent becoming the state-of-the-art and clinically proven medical oral appliance therapy for more than 630,000 patients in 28 countries.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk